Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7982)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2016 (publication date) through Jan 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang HJ, Jiang YF, Wang XR, Zhang ML, Gao PJ. Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B. World J Gastroenterol 2016; 22(18): 4529-4537 [PMID: 27182162 DOI: 10.3748/wjg.v22.i18.4529] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i18/4529.htm |
| Number | Citing Articles |
| 1 |
Qiang Wang, Linna Ma, Caiping An, Steven G. Wise, Shisan Bao. The role of IL-38 in intestinal diseases - its potential as a therapeutic target. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1051787
|
| 2 |
Lihui Xie, Zhaohao Huang, He Li, Xiuxing Liu, Song Guo Zheng, Wenru Su. IL-38: A New Player in Inflammatory Autoimmune Disorders. Biomolecules 2019; 9(8): 345 doi: 10.3390/biom9080345
|
| 3 |
Marie-Astrid Boutet, Aurélie Najm, Géraldine Bart, Régis Brion, Sophie Touchais, Valérie Trichet, Pierre Layrolle, Cem Gabay, Gaby Palmer, Frédéric Blanchard, Benoit Le Goff. IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro. Annals of the Rheumatic Diseases 2017; 76(7): 1304 doi: 10.1136/annrheumdis-2016-210630
|
| 4 |
Soheil Tavakolpour, Hajar Sadat Mirsafaei, Somayeh Elkaei Behjati, Mojtaba Ghasemiadl, Meisam Akhlaghdoust, Shahnaz Sali. Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy. Immunology Letters 2017; 190: 206 doi: 10.1016/j.imlet.2017.08.003
|
| 5 |
Fang Xu, Shihui Lin, Xingxing Yan, Chuanjiang Wang, Hongmei Tu, Yibing Yin, Ju Cao. Interleukin 38 Protects Against Lethal Sepsis. The Journal of Infectious Diseases 2018; 218(7): 1175 doi: 10.1093/infdis/jiy289
|
| 6 |
Weijun Chen, Shuangyun Xi, Yong Ke, Yinlei Lei. The emerging role of IL‐38 in diseases: A comprehensive review. Immunity, Inflammation and Disease 2023; 11(8) doi: 10.1002/iid3.991
|
| 7 |
Alejandro Diaz-Barreiro, Arnaud Huard, Gaby Palmer. Multifaceted roles of IL-38 in inflammation and cancer. Cytokine 2022; 151: 155808 doi: 10.1016/j.cyto.2022.155808
|
| 8 |
Guoqing Huang, Qiankai Jin, Mingcai Li, Xiaoqing Tian, Yushan Mao, Yan Li. The potential value of low-level serum interleukin-38 for the clinical diagnosis and risk prediction of hyperuricemia. International Immunopharmacology 2022; 110: 109069 doi: 10.1016/j.intimp.2022.109069
|
| 9 |
Thomas Garraud, Mathilde Harel, Marie-Astrid Boutet, Benoit Le Goff, Frédéric Blanchard. The enigmatic role of IL-38 in inflammatory diseases. Cytokine & Growth Factor Reviews 2018; 39: 26 doi: 10.1016/j.cytogfr.2018.01.001
|
| 10 |
Abdolreza Esmaeilzadeh, Nazila Bahmaie, Elham Nouri, Mohammad Javad Hajkazemi, Maryam Zareh Rafie. Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study. International Journal of Molecular Sciences 2021; 22(22): 12552 doi: 10.3390/ijms222212552
|
| 11 |
Najmeh Rokhtabnak, Mohammad Reza Ataollahi, Morvarid Asadipour, Mohammad Ali-Hassanzadeh, Pooria Fazeli, Soolmaz Khansalar, Esmaeel Ghani, Kurosh Kalantar. Negative Correlation of Interleukin-38 Serum Level with Alkaline Phosphatase and Persistent Hepatitis C Infection. Shiraz E-Medical Journal 2022; 23(9) doi: 10.5812/semj-121969
|
| 12 |
Yimin Xue, Mingguang Chen, Qian Chen, Tingfeng Huang, Qiaolian Fan, Fenghui Lin, Jun Ke, Feng Chen. Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice. Virology Journal 2021; 18(1) doi: 10.1186/s12985-021-01687-w
|
| 13 |
Dennis M. de Graaf, Lisa U. Teufel, Aline H. de Nooijer, Adriaan J. van Gammeren, Antonius A. M. Ermens, Ildikó O. Gaál, Tania O. Crișan, Frank L. van de Veerdonk, Mihai G. Netea, Charles A. Dinarello, Leo A. B. Joosten, Rob J. W. Arts. Exploratory analysis of interleukin‐38 in hospitalized COVID‐19 patients. Immunity, Inflammation and Disease 2022; 10(11) doi: 10.1002/iid3.712
|
| 14 |
Cheng Xie, Wei Yan, Runze Quan, Chaoyue Chen, Lei Tu, Xiaohua Hou, Yu Fu. Interleukin-38 is elevated in inflammatory bowel diseases and suppresses intestinal inflammation. Cytokine 2020; 127: 154963 doi: 10.1016/j.cyto.2019.154963
|
| 15 |
Xun Gao, Guoqiu Wu, Miranda Sin-Man Tsang, Danqi Huang, Christopher Wai-Kei Lam, Chun Kwok Wong. Novel insights into the role of anti-inflammatory IL-38 in immunity against infection. Cellular & Molecular Immunology 2022; 19(11): 1322 doi: 10.1038/s41423-022-00876-z
|
| 16 |
Dennis M. de Graaf, Lisa U. Teufel, Leo A.B. Joosten, Charles A. Dinarello. Interleukin-38 in Health and Disease. Cytokine 2022; 152: 155824 doi: 10.1016/j.cyto.2022.155824
|
| 17 |
Pooria Fazeli, Mohammadreza Saeidnia, Mehran Erfani, Mehdi Kalani. An overview of the biological and multifunctional roles of IL-38 in different infectious diseases and COVID-19. Immunologic Research 2022; 70(3): 316 doi: 10.1007/s12026-022-09275-y
|
| 18 |
Hua-song Xia, Yue Liu, Yang Fu, Meng Li, Yan-qing Wu. Biology of interleukin-38 and its role in chronic inflammatory diseases. International Immunopharmacology 2021; 95: 107528 doi: 10.1016/j.intimp.2021.107528
|
| 19 |
Bart Boersma, Wim Jiskoot, Peter Lowe, Carole Bourquin. The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy. Cytokine & Growth Factor Reviews 2021; 62: 1 doi: 10.1016/j.cytogfr.2021.09.004
|
| 20 |
Yuan Gao, Luwei Cai, Yulu Wu, Min Jiang, Yidan Zhang, Wenjing Ren, Yirui Song, Lili Li, Ziguang Lei, Youzhuang Wu, Luwen Zhu, Jing Li, Dongya Li, Guohong Li, Chengliang Luo, Luyang Tao. Emerging functions and therapeutic targets of IL‐38 in central nervous system diseases. CNS Neuroscience & Therapeutics 2024; 30(2) doi: 10.1111/cns.14550
|
| 21 |
Lisa U. Teufel, Dennis M. de Graaf, Mihai G. Netea, Charles A. Dinarello, Leo A. B. Joosten, Rob J. W. Arts. Circulating interleukin-38 concentrations in healthy adults. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.964365
|
| 22 |
Maryam Zarrabi, Nasser Gholijani, Saeedeh Shenavandeh, Elham Aflaki, Zahra Amirghofran. IL-38 serum levels in patients with Behcet’s disease and the relationship with clinical features. European Cytokine Network 2019; 30(3): 82 doi: 10.1684/ecn.2019.0430
|
| 23 |
Shakir F Tuleab Alaaraji. Exploration of the Relationship between Interleukins 17, 37 and 38 with Vitamin E in Iraqi Men with CHB.. Journal of Physics: Conference Series 2019; 1294(5): 052047 doi: 10.1088/1742-6596/1294/5/052047
|
| 24 |
Charles Anthony Dinarello. The IL-1 family of cytokines and receptors in rheumatic diseases. Nature Reviews Rheumatology 2019; 15(10): 612 doi: 10.1038/s41584-019-0277-8
|
| 25 |
Jun Cao, Lin Hua, Shipei Zhang, Jinping Tang, Fan Ke, Zhouhuan Wu, Guohui Xue. Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01676-0
|
| 26 |
Jovani Catalan-Dibene, Laura L. McIntyre, Albert Zlotnik. Interleukin 30 to Interleukin 40. Journal of Interferon & Cytokine Research 2018; 38(10): 423 doi: 10.1089/jir.2018.0089
|
| 27 |
Frank L. van de Veerdonk, Dennis M. de Graaf, Leo AB Joosten, Charles A. Dinarello. Biology of IL‐38 and its role in disease. Immunological Reviews 2018; 281(1): 191 doi: 10.1111/imr.12612
|
| 28 |
Abdolreza Esmaeilzadeh, Shabnam Pouyan, Maryam Erfanmanesh. Is Interleukin-38 a key player cytokine in atherosclerosis immune gene therapy?. Medical Hypotheses 2019; 125: 139 doi: 10.1016/j.mehy.2019.02.048
|